Search for: "Sandoz Inc. v. Amgen Inc."
Results 81 - 100
of 112
Sort by Relevance
|
Sort by Date
18 Oct 2015, 10:00 pm
The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. [read post]
18 Oct 2015, 10:00 pm
The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. [read post]
30 Sep 2015, 4:30 am
Amgen, Inc., et al., Case No. 2:12-cv-476 (M.D. [read post]
23 Jul 2015, 9:59 pm
By Andrew Williams -- As we have been reporting this week, the Federal Circuit handed down its decision in Amgen Inc. v. [read post]
21 Jul 2015, 8:27 am
”); TRW Inc. v. [read post]
30 May 2015, 11:03 am
The CAFC will interpret parts of the Biologic Price Competition and Innovation Act (BPCIA) in the case Amgen v. [read post]
22 Mar 2015, 10:00 pm
District Court for the Northern District of California issued an order in Amgen, Inc. v. [read post]
14 Dec 2014, 9:59 pm
Amgen Inc. [read post]
9 Dec 2014, 9:43 pm
By Andrew Williams -- Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's Enbrel® TNF inhibitor. [read post]
8 Dec 2014, 10:00 pm
In Sandoz Inc. v. [read post]
8 Dec 2014, 12:42 pm
by Dennis Crouch Sandoz v. [read post]
11 Apr 2014, 9:42 pm
ACI faculty will help attendees: • Understand the battles over naming and substitution on the federal and state levels and exploring the implications on competition including the FTC's current perspective; • Analyzing the arguments in the first BPCIA case, Sandoz Inc. v. [read post]
27 Aug 2012, 9:31 am
Relying on Amgen Inc. v. [read post]
27 Aug 2012, 9:31 am
Relying on Amgen Inc. v. [read post]
24 Aug 2012, 4:33 pm
Relying on our decision in Amgen Inc. v. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs)… [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
15 Apr 2010, 4:27 am
Sandoz B.V. [read post]
